369 related articles for article (PubMed ID: 22682208)
1. [Clinical management of the new anticoagulants].
Zapata Wainberg G; Ximénez-Carrillo Rico A; Vivancos Mora J
Neurologia; 2012 Mar; 27 Suppl 1():33-8. PubMed ID: 22682208
[TBL] [Abstract][Full Text] [Related]
2. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
3. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
4. [New oral anticoagulants are as safe in elderly patients as conventional drugs].
Steurer J
Praxis (Bern 1994); 2014 Aug; 103(17):1032. PubMed ID: 25146949
[No Abstract] [Full Text] [Related]
5. [Novel oral anticoagulants and atrial fibrillation in the elderly].
Hanon O
Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):34-40. PubMed ID: 24463062
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology and safety of new oral anticoagulants: the challenge of bleeding persists.
Levy JH
Clin Lab Med; 2014 Sep; 34(3):443-52. PubMed ID: 25168936
[TBL] [Abstract][Full Text] [Related]
7. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
8. New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation.
Tripodi A; Palareti G
J Intern Med; 2012 Jun; 271(6):554-65. PubMed ID: 22443239
[TBL] [Abstract][Full Text] [Related]
9. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
Berman JP; Halperin JL
Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
[TBL] [Abstract][Full Text] [Related]
10. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
Lane DA; Wood K
Circulation; 2015 Apr; 131(16):e412-5. PubMed ID: 25901074
[No Abstract] [Full Text] [Related]
11. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Ahmad Y; Lip GY
Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
[TBL] [Abstract][Full Text] [Related]
12. New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.
Tran H; Joseph J; Young L; McRae S; Curnow J; Nandurkar H; Wood P; McLintock C
Intern Med J; 2014 Jun; 44(6):525-36. PubMed ID: 24946813
[TBL] [Abstract][Full Text] [Related]
13. Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
Douketis J; Bell AD; Eikelboom J; Liew A
Can Fam Physician; 2014 Nov; 60(11):989-95. PubMed ID: 25392438
[TBL] [Abstract][Full Text] [Related]
14. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
15. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications.
Fenger-Eriksen C; Münster AM; Grove EL
Acta Anaesthesiol Scand; 2014 Jul; 58(6):651-9. PubMed ID: 24716468
[TBL] [Abstract][Full Text] [Related]
16. [Atrial fibrillation: what the GP needs to know].
Diener HC; Kaeufer T; Bode C
MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796
[No Abstract] [Full Text] [Related]
17. A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.
Kasmeridis C; Lip GY; Apostolakis S
Hosp Pract (1995); 2013 Feb; 41(1):61-70. PubMed ID: 23466968
[TBL] [Abstract][Full Text] [Related]
18. [New clinical perspectives in the management of oral direct anticoagulant agents].
Marco P; Zamorano JL; Chana F; Llau JV
Med Clin (Barc); 2014 Feb; 142(4):171-8. PubMed ID: 23866969
[No Abstract] [Full Text] [Related]
19. The promise of pharmacoepidemiology in helping clinicians assess drug risk.
Avorn J
Circulation; 2013 Aug; 128(7):745-8. PubMed ID: 23940388
[No Abstract] [Full Text] [Related]
20. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
